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ABSTRACT
International Journal of Exercise Science 8(3): 243-255, 2015. Caffeine enhances
aerobic performance, but research is equivocal regarding anaerobic performance. This study
examined effects of caffeine (7 mg/kg) on anaerobic performance in anaerobically active males (n
= 10). Participants completed counterbalanced, double blind caffeine (Caf) and placebo (Pl) trials
including a) 6 x 15 s upper body Wingates (UWant), b) 6 x 15 s lower body Wingates (LWant) and c)
6 x15 s maximal effort static hand grip test (HG) with 3 min recovery between bouts, 30 min
between exercises. Peak power (Ppeak), mean power (Pmean), and heart rate (HR) as well as
perceptual measures included ratings of perceived exertion (RPE), muscle pain perception (MPP),
and perceived recovery status (PRS) were recorded per bout. Session RPE (S-RPE) (15 min post)
for each exercise mode and trial RPE (T-RPE) [10 min post relative to testing period for each
treatment (Caf vs. Pl)]. A series of 2 (trial) x 6 (bout) ANOVA’s assessed differences and Tukey’s
LSD post hoc test were used when necessary. Results showed increased performance (main
effect) (UWant) for Ppeak (Caf: 6.72 + 1.2 W/kg vs. Pl: 6.41 + 1.0 W/kg); and Pmean (Caf: 5.39 + 0.8
W/kg vs. Pl: 5.18 + 0.8 W/kg); however no significant main effect for LWant or HG was observed.
No significant differences were observed for perceptual measures. Caf improved anaerobic
performance in repeated UWant (bouts 1-4) but not LWant or HG. Further studies are warranted to
examine Caf ergogenic properties in repeated exercises dominated by anaerobic metabolic
pathways given the equivocal results.
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INTRODUCTION
Caffeine (Caf) is a central nervous stimulant
and a common constituent of supplements
and energy-drinks based on the premise of
improved physical performance with
associated short term side effects including
headache, nausea, and tremors with mild
consumption. However, long term caffeine
use is not well understood. The National

Collegiate
Athletic
Association
(31)
mandates urinary levels > 15 µg/ml as
illegal for competing athletes. This equates
to 13 mg/kg or roughly 8 cups of coffee (12,
17). Current literature has documented
caffeine as an ergogenic aid in endurance
exercise (For reviews see; Goldstein (14)
and Magkos (29). However, a review by
Davis
(9)
indicates
that
research
investigating caffeine’s impact on anaerobic
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performance has produced equivocal
results, potentially attributable to testing of
untrained individuals and habitual vs. nonhabitual caffeine users, diverse modes of
testing (wingates vs. traditional weight
lifting),
muscle
mass
tested,
and
administration of varying caffeine dosages
(2-10mg/kg).

participant’s body mass and some
participants likely failed to reach critical
levels of caffeine ingestion (i.e. > 3-9 mg/kg
of body mass) previously shown to elicit an
increase in performance (17, 9). Further,
with HG testing, the lack of mode specific
trained
participants
could
mitigate
potential ergogenic properties of caffeine.
Bellar et al. (5) observed a mild (not
significant) difference in HG to time to
failure (Caf: 104.98 + 57.95 s; Pl: 99.85 +
78.39 s) with a concurrent significant
reduction in subjective pain response (Caf:
3.45 + 2.95, Pl: 4.84 + 2.92). It is inconclusive
if the small volume of muscle involved in
HG testing creates a paradigm less
conducive to observing a performanceenhancing effect from caffeine.

Lower body Wingate anaerobic tests (Want)
are an accepted model to assess anaerobic
capacity (23). However, the efficacy of
caffeine on Want performance remains
unclear. Greer (20) and Williams et al. (37)
found caffeine (6-7 mg/kg of body mass)
resulted in no change in repeated (20) or
single effort (37) Wingates ranging from 1530 s. However, the authors attributed
results to the untrained status of
participants. Woolf et al (39) found caffeine
(5 mg/kg) significantly increased total
weight (reps x resistance) lifted for bench
press and peak power for Wingate for
highly fit males. However, total weight
lifted for leg press only approached
significance (p = 0.09). Anselm et al. (2)
showed ingestion of 250 mg of caffeine
prior to exercise increased peak anaerobic
power
in
anaerobically
untrained
participants during a 6 s Want. Additionally,
Kang et al. (26) found caffeine ingestion of
both 2.5 and 5 mg/kg improved Want
performance in untrained individuals.
Conversely, Greer et al. (19) showed
caffeine (6 mg/kg) had no ergogenic effect
during repeated (4 x 30 s) Want with some
evidence caffeine hindered performance in
later bouts.

Caffeine’s ergogenic properties were
originally theorized due to enhanced free
fatty acid mobilization consequent to
glycogen sparing, however this provides
minimal impetus for enhanced performance
(with acute caffeine supplementation)
during exercise dominated by oxygenindependent metabolic pathways justifying
further investigation. However, caffeine has
been shown to have analgesic properties
and a consistent blunting of perceptual pain
responses in steady state exercise (27). Far
less investigation into caffeine’s analgesic
properties in repeated high intensity efforts
has occurred. Caffeine buffers pain (vs.
placebo), evidenced by perceptual and pain
responses being blunted when similar work
is completed or unaltered when greater
work is performed (3, 18, 22, 34).
Additionally, reduction in perceived levels
of pain may be dose dependent per
individual (32).While analgesic potential of
caffeine offers a reasonable mechanism,
discrepancies among previous studies

Bugyi et al. (6) showed no significant
difference in hand grip (HG) strength after
caffeine ingestion of 167, 324, and 500 mg.
However, caffeine dosage was not based on
International Journal of Exercise Science
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make further research warranted to clarify
caffeine’s effect on anaerobic performance.
Additionally, there appears to be a dose
response effect with caffeine to potentially
observe ergogenic benefits (3-7mg/kg).
Therefore, this study examined effects of
caffeine ingestion at 7mg/kg on repeated
upper and lower body Want and hand grip
performance in anaerobically trained males.

Participants followed these instructions and
replicated dietary intake for all subsequent
trials. Descriptions of exercise testing are
included below and were replicated for the
familiarization session and both treatment
sessions. All procedures were approved by
the institutions internal review board (IRB)
and in followed procedures in accordance
with the ethical standards of the Helsinki
Declaration.

METHODS
Table 1. Descriptive characteristics for participants
(n = 10).
Variable
Mean
SD
Age (yrs)
23.9
5.4
Height (cm)
179
6
Body mass (kg)
86.0
10.4
BMI
26.8
2.3
Body Fat (%)
10.9
2.4
Daily caffeine use (mg/day)
189.0
119.7
Daily caffeine use (mg/kg)
2.21
1.3

Participants
Participants were males (ages 19-45) who
frequently engaged in high-intensity
training (HIT) methods involving both
upper and lower body exercises >3
days/week. Participants completed an
informed consent form and were screened
for apparent chronic disease risks using the
PAR-Q (38) and a health questionnaire.
Participants also completed questionnaires
concerning daily caffeine use (33) and
training history. Height (cm) and body
mass (kg) were determined using a
stadiometer (Detecto, Webb City, MO) and
a calibrated digital scale (Tanita BWB-800,
Tokyo, Japan). Body fat percentage was
estimated using skinfold calipers (Lange,
Cambridge, MD) and the three site method
for males (chest, abdomen, thigh) (24).
During each trial, peak heart rate was
obtained using Team2 system heart rate
monitors (Polar Electro Oy, Kempelee,
Finland). Participants were instructed to
report to the lab for testing well-hydrated,
having avoided consumption of caffeine,
alcohol, and any heavy physical exertion 24
h prior to all trials. Participants
documented their dietary intake 24 h prior
to the first session which served as a
familiarization trial and were instructed to
duplicate the diet for each trial.
International Journal of Exercise Science

Protocol
Participants completed a 5 min upper body
cycle specific warm-up on an ergometer
(Ergomedic 828E, Monark Inc., Varberg,
Sweden) equipped with handgrips and
mounted on a table designed for arm
ergometry. Participants completed 6 x 15 s
upper body Want (UWant). Resistance was
individualized at a ratio of 0.062 kp/kg of
body mass (23) and the weight basket was
automatically dropped upon reaching
120rev/min. Each bout was separated by 3
min of passive recovery. Peak power (Ppeak),
mean power (Pmean), and fatigue percentage
(Ftg%) were collected. Subjective data
included rating of perceived exertion (RPE)
for each bout 1 min into recovery. Session
(S-RPE) was collected 15 min after
completion of the last UWant using the
Omni Pictorial 0-10 scale (36). The
Perceived Recovery Scale (PRS) (28) was
used to assess participant’s subjective
feelings of readiness 15 s prior to the start
245
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of each Want on a 10cm visual analog scale
Muscle-pain
perception
(MPP)
was
assessed using a previously validated scale
(8). MPP was assessed after 2 min recovery
following each 15 s Wingate on a 10cm
visual analog scale. Upon completion of the
UWant, participants arm cycled (20-30
rev/min with no resistance) as an active
“cool-down” period for 5 min.

Participants ingested either caffeine (Caf) (7
mg/kg) or matched placebo (Pl) pills
(lactose) in soft capsule form, 1 h prior to
reporting to the laboratory. The primary
investigator prepared paired sets of pills
(Caf and Pl) in clear storage bags and
received verbal confirmation of ingestion 1
hr prior to trial by the participant. Caf and
Pl
trials
were
completed
in
a
counterbalanced order and in a doubleblind manner.

Participants recovered in a seated position
for 30 min upon the completion of the last
UWant before the lower body Want (LWant).
LWant were conducted in the exact manner
as UWant Participants completed a 5 min
warm-up at a standardized 50-60 rev/min
(with no resistance) on a cycle ergometer
(Ergomedic 894E, Monark Inc., Varberg,
Sweden). Participants completed 6 sets of
15 s LWant. Resistance was a ratio of 0.087
kp/kg of body mass (23) and the weight
basket was automatically dropped upon
reaching 120rev/min. Upon completion of
the last LWant, participants cycled 5 min at
30-40 rev•min-1 with no resistance as an
active “cool-down”.

Statistical Analysis
Data was analyzed utilizing SPSS and an
alpha of 0.05 was set a priori. A series of 2
(trial) x 6 (Wingate) repeated measures
ANOVA’s were used to compare
dependent
measures
including
performance (Ppeak, Pmean, Ftg%)
and
perceptual data (MMP, RPE, and PRS). A
two-way repeated-measures ANOVA and
Tukey’s LSD post hoc test were used to
examine differences in HR. Session RPE
and Trial RPE were analyzed between Caf
and Pl trials using paired samples T-test per
exercise mode.
RESULTS

Participants completed 6 x 15 s maximal
effort hand grip strength tests (HG) with
each hand (Baseline Hydraulic Hand
Dynamometer, Fabrication Enterprises Inc.,
Irvington, NY) after completion U and L
Want. Participants completed the trials in a
standing position, arms at sides, and
dominant hand first. Each bout was
separated by 3 min passive recovery. Peak
and minimum power, RPE, MPP, PRS, and
S-RPE were recorded in the same manner
as with Wingate testing. Trial (T-RPE) was
collected 20 min after completion of trial
(Caf and Pl) using the Omni Pictorial 0-10
scale (36).
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Descriptive data are shown in Table 1. Trial
means for performance are shown in Table
2. Upper Body Wingate: A significant main
effect for trial was observed for Ppeak
(Figure 1) and Pmean (Figure 2). Follow up
tests showed significantly greater values for
CA for Ppeak on bouts 1 and 2 (Figure 1) and
for Pmean for bouts 1, 2 and 4 (Figure 2). No
significant difference was observed for HR
(b/min) (Caf: 158 + 16 vs. Pl: 158 + 10). No
Significant differences were found for Ftg%
(Caf: 60.5 + 1.4 %vs. Pl: 60.5 + 3.5 %), RPE,
MPP, PRS, S-RPE. No significant difference
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was found in T-RPE (Caf: 6.2 + 0.8 vs. Pl: 5.9
+ 1.4).

(Caf: 59.2 + 2.9 % vs. Pl: 59.2 + 4.0 %), RPE,
MPP, or S-RPE (Table 2).

Figure 1. Caf vs. Pl UWant Ppeak. *Caf significantly
higher than Pl per bout. Caf significantly higher
than Pl, p = 0.04 (main effect).

Figure 3. Caf vs. Pl UWant Pmean. *Caf significantly
higher than Pl. Caf significantly higher than Pl, p =
0.009 (main effect).

Figure 2. Caf vs. Pl LWant Ppeak. * Pl significantly
higher than Caf p = 0.04.

Figure 4. Caf vs. Pl LWant Pmean. *Pl significantly
higher than Caf. Pl significantly higher than Caf, p =
0.03 (main effect).

Follow up tests showed significantly
greater values for Pl for PRS on bouts 4, 5,
and 6. No significant difference was
observed for mean LWant Ppeak (Figure 3). A
significant main effect was observed for
Pmean (Figure 4). Follow up tests showed
significantly greater values for Pl for Pmean
on bout 6 (Figure 4).HR was significantly
different for LWant (Caf: 163 + 7 b/min vs.
Pl: 158 + 8 b/min) and follow up tests
showed significantly greater values for Caf
for HR on bouts 2, 3, 4, 5, and 6.
Additionally, LWant PRS was significantly
higher for Pl (Table 2) No significant
differences were observed for LWant Ftg%

International Journal of Exercise Science

No significant differences were found
between trials for HG peak power (Caf: 52.7
+ 1.7 kg vs. Pl: 53.0 + 1.3 kg), RPE, MPP, or
PRS. HG HR (b/min) was found
significantly higher (Caf: 130 + 15, vs. Pl:
122 + 16) and follow up tests showed
significantly greater values for Caf for HR
for all bouts No significant difference was
found in HG S-RPE (Table 2).
DISCUSSION
The major finding of the current study was
7 mg/kg of Caf resulted in a significant
247
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Table 2. Perceptual data for Caf vs. Pl. Means and
standard deviations.
Variable
UWant RPE mean
LWant RPE mean
HG RPE mean
UWant PRS
LWant PRS
HG PRS
UWant MPP
LWant MPP
HG MPP
UWant S-RPE
LWant S-RPE
HG S-RPE

Caffeine
5.5 + 1.6
6.1 + 1.6
3.3 + 1.5
5.3 + 2.2
5.0 + 2.2
7.1 + 1.9
4.1 + 2.4
4.8 + 1.8
2.3 + 1.5
6.1 + 1.4
7.0 + 0.9
3.4 + 1.5

Placebo
5.2 + 1.3
5.8 + 1.5
2.7 + 1.2
5.7 + 1.8
5.7 + 1.9
7.6 + 1.3
3.9 + 1.8
4.2 + 2.2
2.0 + 1.4
5.8 + 1.1
6.4 + 1.5
3.4 + 1.7

recovery) in attempt simulate match day for
wrestlers. Caffeine negatively impacted
performance in upper body ergometry (p=
0.05) but not in the placebo trial.
Conversely, we found caffeine improved
performance in upper body ergometry.
However, this could be attributed to the
shorter duration (15 s vs. 6 min) of exercise
bouts in the current study. Beck et al. (4)
examined acute caffeine supplementation
on trained individuals between multiple
muscle groups in traditional weight lifting
exercises (leg extension and bench press)
and repeated (2) Want, observing improved
performance for upper body, but not lower
body. Green et al. (18) found caffeine
significantly increased reps to failure
during leg press in the third (but not first
two) of three sets, but in none of three sets
for bench press. Hudson et al. (22) tested
trained individuals on upper body (arm
curls) and lower body (leg extensions)
resistance exercise. Leg extension and arm
curl reps to failure significantly improved
(attributed to first two of four sets to
failure). Current results were similar to
Beck et al. (4) in that caffeine’s ergogenic
properties were limited to upper body
exercise and not lower body. Hudson et al.
(22) also observed improved performance
for upper body exercise that was limited to
the first two sets (and not the later sets).
However, Green et al. (18) contradict the
current
study,
where
significant
improvement was observed in the early sets
(1st and 2nd), but not in the later UWant
possibly because the intense fatigueinducing nature of UWant. Additionally,
mean RPE for UWant approached
significance (p = 0.16) systematically
increasing with the increased volume of
work performed. Though no significant
difference was observed for UWant Caf vs.

p value
0.16
0.11
0.41
0.23
0.02
0.17
0.43
0.13
0.21
0.09
0.20
0.50

increase in Ppeak and Pmean in UWant Caf,
while no significant difference was
observed in Ppeak in LWant and HG
performance. However, Caf resulted in a
significantly greater Pmean in LWant .
Further, RPE for UWant was not
significantly different but group means
were higher for Caf vs. Pl (Table 2)
corresponding with higher Ppeak following
caffeine ingestion indicating subjective
feelings reflected increased work. Caf vs. Pl
RPE in UWant 4 was not significant (Caf: 5.8
+ 1.3, Pl: 5.4 + 0.8) (p = 0.16). Caf vs. Pl
UWant S-RPE was not significantly different
(Caf: 6.1 + 1.4, Pl: 5.98+ 1.1), although
performance was greater following Caf
ingestion.
Collectively,
perceptual
responses considered concurrent with
performance between trials suggests
caffeine may blunt perceived exertion and
pain response allowing for increased
volume of work.
Currently there is limited data on caffeine’s
ergogenic potential in upper body
ergometry. Recent investigation by Aedma
et al (1) impact of caffeine supplementation
(5mg/kg) utilizing repeated upper body
ergometry efforts (4 x 6 min, 30 min
International Journal of Exercise Science
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Pl, similar peak HR responses (158 + 16
b/min vs. 158 + 11 b/min) with greater
power output during Caf may offer
evidence of caffeine’s ergogenic properties.

muscle volume. However, it is also
reasonable that highly trained individuals
may also be more likely to experience
improvement if caffeine’s ergogenic benefit
is rooted in adenosine receptor antagonism.
Because untrained muscle lacks neural
adaptation (vs. trained muscle), a lower
percentage and absolute number of total
fibers may be activated during work.
Consequently, there is less opportunity an
ergogenic benefit to manifest through
adenosine receptor antagonism. This theory
has not been directly investigated yet could
partially
explain
observations
of
improvement in trained and not in
untrained
participants.
Further
investigation is needed to clarify the
potential role of muscle volume and
training status with regard to caffeine, in
particular, mechanistic factors.

The equivocal nature of the literature
regarding
upper
vs.
lower
body
performance and caffeine is difficult to
explain; however, muscle volume recruited
may be a key factor. Svenningsson et al.
(35) found increased motor unit activity in
rats via antagonism of adenosine receptors
at doses of caffeine of 7.5 mg/kg. Assuming
greater muscle volume contains a greater
absolute volume of adenosine receptors, it
is plausible that individuals with a higher
overall volume of muscle mass may
potentially respond more positively to
caffeine supplementation, although direct
evidence is lacking. Given the “trained” (vs.
sedentary) status of current participants,
the expectation for improved performance
would be plausible based on the previous
statement. However, various performance
tasks may differ following acute caffeine
supplementation based on muscle volume
involved in testing which is often dictated
by testing mode. The results of the current
study potentially support the previously
stated theory given the improved
performance for upper body, similar to
Beck et al. (4), but not lower body,
contradicting the results of Green et al. (18)
and Hudson et al. (22) (see figure 1, 2, 3).
Though the results of the studies are
contradictory regarding muscle body
regions that experienced performance
differences; all three studies utilized trained
individuals and observed a positive effect
from caffeine in at least one body region.

Current results for LWant support Collomp
et al. (7), Williams et al. (37), and Greer et
al. (19) that Caf had no effect on LWant
performance. Williams et al. (37) observed
caffeine having no effect on mean power in
15 s maximal effort cycling. Greer et al. (19)
utilized a similar Caf does (6 mg/kg) and
found peak and mean performance did not
improve on the first 3 of 4 consecutive
LWant but did increase on the final bout.
However, it is important to note the
participants in Greer et al (19) were
unaccustomed to intense exercise. Plausibly
no effect was observed because the
utilization
of
untrained
individuals
prevented potential benefits from caffeine
supplementation. Similarly, testing of nonhabitual users creates the potential for
caffeine-induced nausea which may impair
performance at 6 mg/kg of caffeine (21).
However the current study included
trained individuals while finding a

Greater absolute adenosine receptor
volume would be anticipated with greater
International Journal of Exercise Science
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significant difference between Pl vs. Caf
Pmean LWant (Figure 4). Additionally, RPE in
the 6th Want was significantly higher (p =
0.02, Caf: 7.6 + 0.8 vs. Pl: 6.9 + 1.0).
Astorino et al. (3) found similar RPE and
pain levels during leg extensions (2 sets of
40) Caf (5mg/kg) vs. Pl demonstrating a
lack of pain blunting effect of caffeine on
RPE similar to the current study. It is
unclear why RPE was higher given the lack
of differences in performance in the current
study. LWant always followed UWant bouts
and significantly greater performance was
observed for Caf trials during UWant (Figure
2). While remote, it is possible that, because
LWant followed the upper body bouts, RPE
was higher during Caf because of greater
“pre” fatigue resulting from greater work
volume during Caf UWant (Table 2).
Interesting to note, LWant PRS was
significantly higher for Pl vs. Caf (5.68 + 1.9
vs. 5.00 + 2.2). Greater PRS demonstrated
participant’s subjective feelings of greater
recovery and preparedness for ensuing
bouts during Pl. This potentially supports
the concept that lack of a significant
difference for LWant may be attributed to
residual fatigue from UWant. A negative
reaction to high caffeine dosage can
arguably be eliminated as no adverse
reactions were observed or reported by
participants.

respond
positively
to
caffeine
administration. Our mode (repeated
maximal static efforts) could negate any
potential ergogenic response given the
small volume of muscle utilized during
hand grip testing. If a critical level of
muscle volume is necessary to observe an
ergogenic effect from caffeine, detection of
improved performance would be difficult
in the current (handgrip testing) paradigm.
No analgesic effect of caffeine was observed
in HG MPP (Table 2) in the current study
contradicting Bellar et al. (5) who found
pain perception was lowered by caffeine in
hand grip to exhaustion Caf even when
group means for time to exhaustion were
higher Caf. However, the contradiction in
perceptual ratings potentially could be
attributed to mode of testing (15 s vs. time
to exhaustion). Greater exercise duration
(~100 s vs. a standardized 15 s) would have
the potential to generate greater pain levels
creating a situation in which caffeine, as an
analgesic, might have greater potential to
function. Lack of differences in HG MPP,
with similar power, supports the notion
that pain perception is influenced by
volume of muscle performing work (i.e.
relationship between muscle volume and
volume of work performed influence on
pain perception) and in this paradigm
caffeine failed to influence MPP.

Similar to Bugyi et al. (6), the current study
showed no significant difference in mean
hand grip performance between Caf vs. Pl
trials. However, unlike the current study,
caffeine dosage was not based on
participant’s body mass in Bugyi et al. (6).
Basing dosage on participant body mass
plausibly ensured that critical levels of
caffeine to induce potential ergogenic
effects were reached in those who would

During high intensity exercise, caffeine has
demonstrated analgesic properties and
consistent blunting effect on perceptual
responses (10, 30). Although no difference
was observed in power levels, RPE
approached significance during Pl LWant (p
= 0.11), failing to provide strong support for
caffeine’s hypoalgesic effects of a lower
RPE at the same workload (Caf: 3.42 + 1.50
vs. Pl: 3.27 + 1.71). It is plausible that

International Journal of Exercise Science
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caffeine buffers pain as similar or increased
work is performed (caffeine vs. placebo
trials); yet perceptual responses are blunted
or unaltered respectively (3, 18, 22, 34).
Furthermore,
current
results
show
perceptual pain measures systematically
increased with increased muscle volume
utilized (Table 2). Additionally, reduction
in reported levels of pain may be dose
dependent due to individual variability
required to reach critical levels (32). Killen
et al. (27) observed significantly lower
Session-RPE for Caf vs. Pl (6.1 ± 2.2 vs. 6.8 ±
2.1) following 30 min of sub-max cycling
equated for intensity and total work
volume. In the current study, S-RPE was
not significantly different for any exercise,
nor was T-RPE significantly different for
Caf. However, group means were higher
for all 3 exercises Caf vs. Pl RPE (Table 2).
The contradictory results between studies
may potentially be explained by mode of
exercise (aerobic vs. anaerobic). As stated
earlier, LWant PRS was significantly higher
for Pl (vs. Caf), but no significant difference
was observed for PRS in UWant or HG;
however, group means were higher for all
exercises during Pl (Table 2). This indicates
the high caffeine dosage may have
impacted some participants negatively
given the subjective measures show
participants anticipated performing better
on the ensuing bout (when not on caffeine).
Laurent et al. (28) demonstrated a
correlation between expected performance
using the PRS scale and actual performance
for the ensuing exercise bout. In that study
recovery (PRS) was estimated prior to an
entire exercise bout following variable days
of recovery. In the current study, PRS was
taken repeatedly between bouts essentially
reflecting participant’s perceived readiness
for the next bout. Results were inconclusive
International Journal of Exercise Science

given participants performed better during
the UWant Caf trial but PRS group means
were higher during Pl; LWant Pmean was
higher during Pl and correlated with a
higher PRS, while HG max performance
was not statistically different nor was PRS
(though group mean was higher during Pl).
PRS responses and performance in the
current study was potentially disrupted by
the acute caffeine supplementation and the
way in which the PRS scaled was applied.
The PRS scale was intended to assess
recovery status prior to exercise in a global
manner and has not been validated to
function as a readiness scale between acute
repeated bouts. Even so, it is conceivable
that the subjective scale (PRS) lacked
sensitivity to detect the small differences in
performance in the current design. Further
investigation is needed to determine how
caffeine ingestion may alter perceptual
feelings regarding recovery status.
Because there appears to be inter-individual
variability regarding caffeine’s’ ergogenic
potential, conclusions based solely on
analysis of mean data may be misleading. It
is therefore important to consider
individual responses. In the current study
7/10 individuals consumed caffeine daily
at rates > 1.8mg/kg. Of these 7 habitual
users, 6 showed mean improvement
following Caf (vs Pl) ingestion for Peak for
UWant (0.61W/kg) and LWant 0.44 W/kg),
while the single non-responder (Pl > Caf
performance) possessed the highest BF % in
the study and produced the lowest W/kg
UWant, Pmean and LWant, Pmean in the current
study (supporting earlier speculation based
on Svenningsson et al. (35)). Although,
aggregate data show no significant
difference in LWant
Ppeak, individual
responders
to
acute
caffeine
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supplementation improved LWant Ppeak
between 0.22-1.34 W/kg (~ 21-131 Watts).
Additionally, the responders improved
UWant, Ppeak (0.34-1.04 W/kg) or (~ 33-102
Watts). Comparatively the 3 designated
non-responders demonstrated average
valued reflecting impaired performance for
UWant, Ppeak (-0.07 W/kg or -6.65 Watts) and
LWant, Ppeak (-0.14 W/kg or -13.3 Watts) Caf
vs. Pl. Woolf et al. (39) tested collegiate
football players after ingestion of 5 mg/kg
on 40-yard sprint, 20-yard shuttle test, and
bench press reps to failure, showing no
significant difference between placebo and
caffeine trials when comparing group
means. However, 59% of participants
improved 40-yard sprint time; 59%
improved 20-yard shuttle time, and 47%
improved bench press reps to failure.
Similar to current results, Woolf’s study
emphasizes that it is imperative to examine
‘responders vs. non-responders’ (i.e.
individual data) to provide an in-depth
evaluation regarding effects of caffeine on
anaerobic exercise. Similarly, Jordan et al.
(25)
examined
acute
caffeine
supplementation at 6 mg/kg on repeated
sprints (12 x 30 m) between caffeine naïve
(<50 mg per day) and habitual (>300 mg
per day) college age males and females. No
significant differences were found between
Caf consumers and non-consumers in
performance. However fastest individual
sprint time for all participants followed
caffeine consumption. Additionally, mean
sprint times for the caffeine trial were faster
compared to mean sprint times for the
placebo trial and mean RPE was higher
during the caffeine trial compared to the
placebo trial (13.9 + 1.5 vs. 13.3 + 1.6). While
significant differences in sprint times were
not identified based on common values
used to restrict type I error rate, it is
International Journal of Exercise Science

emphasized
that
seemingly
minor
differences
in
anaerobic
athletic
competitions can be of great practical
importance.
More research is required to definitively
determine the effect of caffeine on intense
anaerobic exercise. One flaw of acute
caffeine supplementation research is a clear
consensus on what constitutes a habitual
caffeine user.. Future studies should define
habitual users using daily intake relative to
body mass (mg/kg) rather than daily
absolute caffeine ingestion. Caffeine should
be administered during a multitude of
activities in dosages at or above levels
previously shown to enhance performance.
The
ability
to
mask
caffeine
supplementation is difficult, but 6 out of 10
participants incorrectly guessed which
treatment they received first and was
considered but a direct analysis was
omitted. However, one constant that should
remain is the utilization of anaerobically
trained individuals. In Davis’ (9) review, of
18 studies showing an ergogenic effect of
caffeine, 15 utilized trained individuals, 2
untrained and 1 did not provide training
background. Further investigations should
focus on more practical approaches
reflecting
athletic
competitions
and
training, utilizing a strength-to-weight
ratio. It is also critical to assess individual
responses rather than drawing conclusions
based solely on analysis of aggregate data.
The current study demonstrated caffeine’s
ergogenic properties in certain paradigms
(upper body wingates during early sets)
and failure to influence performance in
others (lower body wingates and static
hand grips). Plausibly, caffeine’s ergogenic
properties may be limited to trained
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http://www.intjexersci.com

CAFFEINE AND UPPER BODY WINGATE PERFORMANCE
to exhaustion task. J Strength Cond Res 25(5): 12251228, 2011.

individuals targeting appropriate muscle
mass (mode and set dependent) following
ingestion of a required critical dosage.
Given a large dose of caffeine, acute
negative side effects are plausible which
could hinder performance. Additionally,
research should not focus only on
performance variables; instead continue to
investigate perceptual responses to caffeine
during
exercise.
Admittedly,
one
confounder of caffeine research is the
dynamic variability in methodology
making it problematic to compare findings
to identify a definitive, global answer
regarding caffeine’s potential impact on
exercise bouts dominated by anaerobic
metabolic ATP production.
Therefore
research should continue to focus on the
responder vs. non-responder concept in
attempts to identify the parameters that
create a responder to caffeine’s ergogenic
properties.

6. Bugyi GJ. The effects of moderate doses of caffeine
on fatigue parameters of the forearm flexor muscles.
Am Corr Ther J 34: 49-53, 1980.
7. Collomp K, Ahmaidi M, Audran M. Effects of
caffeine ingestion on performance and anaerobic
metabolism during the Wingate test. Int J Sports
Med 12: 439-443, 1991.
8. Cook BC, O’Connor PJ, Oliver SE, Lee Y. Sex
differences in naturally occurring leg muscle pain
and exertion during maximal cycle ergometry. Int J
Nuero Sci 95(34): 183-202, 1998.
9. Davis JK, Green, JM. Caffeine and anaerobic
performance: ergogenic value and mechanisms of
action. Sports Med 39 (10): 813-832, 2009.
10. Doherty M, Smith PM, Hughes MG, Davison RC.
Caffeine lowers perceptual response and increases
power output during high-intensity cycling. J Sport
Sci 22(7): 637-643, 2004.
11. Dotan R, Bar-Or. Load optimization for the
wingate anaerobic test. Eur J Appl Physiol 51:409–
417, 1983.
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